Skip to main content
. 2022 Apr 12;10(4):591. doi: 10.3390/vaccines10040591

Figure 1.

Figure 1

Overview of the major technology platforms used for COVID-19 vaccine development, the SARS-CoV-2 variants of concern and their respective spike protein mutations, and the factors that may influence the effectiveness of available vaccines. Adapted from Tregoning et al. [44] and Mistry et al. [94]. Created with BioRender.com (accessed on 17 February 2022).